These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 18470646)

  • 21. The long terminal repeat negative control region is a critical element for insertional oncogenesis after gene transfer into hematopoietic progenitors with Moloney murine leukemia viral vectors.
    Ikawa Y; Uchiyama T; Jagadeesh GJ; Candotti F
    Gene Ther; 2016 Nov; 23(11):815-818. PubMed ID: 27487944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Promoter choice for retroviral vectors: transcriptional strength versus trans-activation potential.
    Weber EL; Cannon PM
    Hum Gene Ther; 2007 Sep; 18(9):849-60. PubMed ID: 17767401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Type and position of promoter elements in retroviral vectors have substantial effects on the expression level of an enhanced green fluorescent protein reporter gene.
    Flasshove M; Bardenheuer W; Schneider A; Hirsch G; Bach P; Bury C; Moritz T; Seeber S; Opalka B
    J Cancer Res Clin Oncol; 2000 Jul; 126(7):391-9. PubMed ID: 10929761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genotoxicity assay for gene therapy vectors in tumor prone Cdkn2a⁻/⁻ mice.
    Montini E; Cesana D
    Methods Enzymol; 2012; 507():171-85. PubMed ID: 22365774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative clonal analysis of reconstitution kinetics after transplantation of hematopoietic stem cells gene marked with a lentiviral SIN or a γ-retroviral LTR vector.
    Cornils K; Bartholomae CC; Thielecke L; Lange C; Arens A; Glauche I; Mock U; Riecken K; Gerdes S; von Kalle C; Schmidt M; Roeder I; Fehse B
    Exp Hematol; 2013 Jan; 41(1):28-38.e3. PubMed ID: 22989760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrent retroviral vector integration at the Mds1/Evi1 locus in nonhuman primate hematopoietic cells.
    Calmels B; Ferguson C; Laukkanen MO; Adler R; Faulhaber M; Kim HJ; Sellers S; Hematti P; Schmidt M; von Kalle C; Akagi K; Donahue RE; Dunbar CE
    Blood; 2005 Oct; 106(7):2530-3. PubMed ID: 15933056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biochemical correction of X-CGD by a novel chimeric promoter regulating high levels of transgene expression in myeloid cells.
    Santilli G; Almarza E; Brendel C; Choi U; Beilin C; Blundell MP; Haria S; Parsley KL; Kinnon C; Malech HL; Bueren JA; Grez M; Thrasher AJ
    Mol Ther; 2011 Jan; 19(1):122-32. PubMed ID: 20978475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deletion of the LTR enhancer/promoter has no impact on the integration profile of MLV vectors in human hematopoietic progenitors.
    Moiani A; Miccio A; Rizzi E; Severgnini M; Pellin D; Suerth JD; Baum C; De Bellis G; Mavilio F
    PLoS One; 2013; 8(1):e55721. PubMed ID: 23383272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced genotoxicity of avian sarcoma leukosis virus vectors in rhesus long-term repopulating cells compared to standard murine retrovirus vectors.
    Hu J; Renaud G; Gomes TJ; Ferris A; Hendrie PC; Donahue RE; Hughes SH; Wolfsberg TG; Russell DW; Dunbar CE
    Mol Ther; 2008 Sep; 16(9):1617-23. PubMed ID: 18578011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leukemia induction after a single retroviral vector insertion in Evi1 or Prdm16.
    Modlich U; Schambach A; Brugman MH; Wicke DC; Knoess S; Li Z; Maetzig T; Rudolph C; Schlegelberger B; Baum C
    Leukemia; 2008 Aug; 22(8):1519-28. PubMed ID: 18496560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retroviral vectors containing chimeric promoter/enhancer elements exhibit cell-type-specific gene expression.
    Couture LA; Mullen CA; Morgan RA
    Hum Gene Ther; 1994 Jun; 5(6):667-77. PubMed ID: 7948129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clonal dominance of hematopoietic stem cells triggered by retroviral gene marking.
    Kustikova O; Fehse B; Modlich U; Yang M; Düllmann J; Kamino K; von Neuhoff N; Schlegelberger B; Li Z; Baum C
    Science; 2005 May; 308(5725):1171-4. PubMed ID: 15905401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retroviral vectors produced in the cytoplasmic vaccinia virus system transduce intron-containing genes.
    Konetschny C; Holzer GW; Falkner FG
    J Virol; 2002 Feb; 76(3):1236-43. PubMed ID: 11773399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Solving the problem of γ-retroviral vectors containing long terminal repeats.
    Persons DA; Baum C
    Mol Ther; 2011 Feb; 19(2):229-31. PubMed ID: 21289636
    [No Abstract]   [Full Text] [Related]  

  • 35. Insertion of retroviral vectors in NOD/SCID repopulating human peripheral blood progenitor cells occurs preferentially in the vicinity of transcription start regions and in introns.
    Laufs S; Nagy KZ; Giordano FA; Hotz-Wagenblatt A; Zeller WJ; Fruehauf S
    Mol Ther; 2004 Nov; 10(5):874-81. PubMed ID: 15509505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stem cell marking with promotor-deprived self-inactivating retroviral vectors does not lead to induced clonal imbalance.
    Cornils K; Lange C; Schambach A; Brugman MH; Nowak R; Lioznov M; Baum C; Fehse B
    Mol Ther; 2009 Jan; 17(1):131-43. PubMed ID: 19002163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insertional mutagenesis by retroviral vectors: current concepts and methods of analysis.
    Knight S; Collins M; Takeuchi Y
    Curr Gene Ther; 2013 Jun; 13(3):211-27. PubMed ID: 23590635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current advances in retroviral gene therapy.
    Yi Y; Noh MJ; Lee KH
    Curr Gene Ther; 2011 Jun; 11(3):218-28. PubMed ID: 21453283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcriptional activity of the CD45 gene promoter in retroviral vector constructs.
    Anson DS; Occhiodoro T
    Biochim Biophys Acta; 1994 Sep; 1219(1):81-8. PubMed ID: 8086481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple modifications allow high-titer production of retroviral vectors carrying heterologous regulatory elements.
    Hlavaty J; Stracke A; Klein D; Salmons B; Günzburg WH; Renner M
    J Virol; 2004 Feb; 78(3):1384-92. PubMed ID: 14722293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.